CDRH Director Shuren: Preventive Actions Could Curb FDA Warning Letters
This article was originally published in The Gray Sheet
Executive Summary
FDA device center director Jeffrey Shuren is asking manufacturers to make a renewed push to ensure their quality systems are doing what they are supposed to do - prevent product problems. Among the results, he suggested, might be fewer warning letters from FDA